<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04873544</url>
  </required_header>
  <id_info>
    <org_study_id>KY20170418-02</org_study_id>
    <nct_id>NCT04873544</nct_id>
  </id_info>
  <brief_title>Enhanced Recovery After Surgery Protocols in Total Knee Arthroplasty Via Midvastus Approach</brief_title>
  <official_title>Enhanced Recovery After Surgery Protocols in Total Knee Arthroplasty Via Midvastus Approach</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nanjing First Hospital, Nanjing Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nanjing First Hospital, Nanjing Medical University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aimed to investigate the impact of enhanced recovery after surgery (ERAS) protocols&#xD;
      on the clinical effect of total knee arthroplasty (TKA) via the midvastus approach&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this study, a randomized controlled study was conducted to further investigate the impact&#xD;
      of ERAS protocols in the clinical efficacy of TKA with the midvastus approach. The ERAS&#xD;
      protocols were adopted for the ERAS group and consisted of pure juice drinking 2 hours before&#xD;
      the surgery, optimization of the preoperative anesthesia plan, phased use of tourniquets, and&#xD;
      the use of tranexamic acid as well as a drug cocktail. The operative time, first&#xD;
      postoperative walking time, first straight leg elevation time, postoperative hospitalization&#xD;
      time, visual analogue scale score (VAS score), New York Hospital of Special Surgery knee&#xD;
      score (HSS score), Knee Society Score (KSS score), and knee range of motion were used to&#xD;
      assess the clinical effects in the two groups. All the included patients were followed up for&#xD;
      12 months.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 1, 2018</start_date>
  <completion_date type="Actual">June 30, 2020</completion_date>
  <primary_completion_date type="Actual">June 30, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the postoperative hospitalization time</measure>
    <time_frame>12 months</time_frame>
    <description>the postoperative hospitalization time</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>the operative time</measure>
    <time_frame>2 hours</time_frame>
    <description>the operative time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>first postoperative walking time</measure>
    <time_frame>1 day</time_frame>
    <description>first postoperative walking time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>first straight leg elevation time</measure>
    <time_frame>1 day</time_frame>
    <description>first straight leg elevation time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>visual analogue scale score (VAS score)</measure>
    <time_frame>12 months</time_frame>
    <description>VAS score (0-10 scores) is for pain: 0 represent no pain, 1-3 represent mild pain, 4-6 represent moderate pain, 7-10 represent severe pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>New York Hospital of Special Surgery knee score (HSS score)</measure>
    <time_frame>12 months</time_frame>
    <description>HSS score (0-100 scores) is for knee function: 85-100 represent excellent, 70-84 represent good, 60-69 represent fair, 0-59 represent bad.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Knee Society Score (KSS score)</measure>
    <time_frame>12 months</time_frame>
    <description>KSS score (0-100 scores) is for knee function: 85-100 represent excellent, 70-84 represent good, 60-69 represent fair, 0-59 represent bad.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>knee range of motion</measure>
    <time_frame>12 months</time_frame>
    <description>knee range of motion</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">69</enrollment>
  <condition>ERAS</condition>
  <condition>Knee Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>Common protocols for TKA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Common protocols for TKA</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ERAS protocols for TKA</intervention_name>
    <description>ERAS protocols for TKA</description>
    <arm_group_label>Common protocols for TKA</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Unilateral primary knee osteoarthritis&#xD;
&#xD;
          -  Varus, valgus, and flexion contracture deformity of the knee joint &lt; 10°&#xD;
&#xD;
          -  The range of motion of the knee joint was &gt; 80°&#xD;
&#xD;
          -  Body mass index (BMI) &lt; 30&#xD;
&#xD;
          -  No previous history of knee surgery on the affected side .Agreed to participate in the&#xD;
             trial.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Rheumatoid arthritis&#xD;
&#xD;
          -  Extra-knee deformity&#xD;
&#xD;
          -  Simultaneous bilateral knee arthroplasty&#xD;
&#xD;
          -  Severe dysfunction of the liver, kidney, and blood system&#xD;
&#xD;
          -  Severe cardiovascular diseases&#xD;
&#xD;
          -  Gastrointestinal ulcer .Other medical conditions like nausea, vomiting, snoring, and&#xD;
             allergy to related analgesic drugs.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>56 Years</minimum_age>
    <maximum_age>74 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Nanjing first hospital</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210029</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>April 30, 2021</study_first_submitted>
  <study_first_submitted_qc>April 30, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 5, 2021</study_first_posted>
  <last_update_submitted>May 5, 2021</last_update_submitted>
  <last_update_submitted_qc>May 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

